Richard has been the CEO of several technology-based companies and is active in the Silicon Valley community. As CEO, he has taken two companies from concept to profitability and sold others to public companies. He has a strong financial and operations background with an MBA from UC Berkeley; public accounting experience with PWC and banking experience as a founder and director of Silicon Valley Bank. He was a Chairman of the American Electronics

Bob has worked for over 20 years in the biotechnology industry in companies such as Syva, Syntex, Becton Dickinson, LJL Biosystems/Molecular Devices, Guava Technologies, and, most recently, Charisela. This provides him with a vast range of experience crucial for insuring development of a successful company in this field. Mr. Danielzadeh’s experience includes: assay development, applications, manufacturing, project leadership, quali

is a member of Charisela's Scientific Advisory Board. He is an Adjunct Professor UCSF, Department of Laboratory Medicine; an Associate Director and Associate Investigator, BSRI; Associate Director Clinical Professor, UCSF, Department of Medicine. He received his M.D. degree from Columbia and his B.A and B.S. degrees from UC Berkeley.

Dan is Chairman of Charisela’s Scientific Advisory Board and an investor in the Company. He was a 30-year member of the UCSF faculty, a Director of the Clinical Immunology Lab at UCSF, and Chairman of the Department of Clinical Pathology with responsibility for its 4 large clinical laboratories. He received his MD degree from Stanford University.

Phil is a member of the Board of Directors and an investor in the Company. Phil has been CEO and on the Boards of numerous public and private companies including California Microwave, General Cellular, and Optical Communication Products. He has also been a strategic and financial consultant for companies in several technology-oriented industries. Phil has a Harvard MBA and an undergraduate degree in engineering from Yale University.

UCSF Helen Diller Family Comprehensive Cancer Center. For more than two decades he has been director of The Lab for Cell Analysis at the University of California, San Francisco, where he has authored over 100 peer-reviewed publications and issued four scientific technology patents. He holds degrees in Chemistry and Biochemistry from The George Washington University of Washington, D.C.

Matthias Hebrok, PhD.
is the Hurlbut-Johnson Distinguished Professor in Diabetes Research and Director of the UCSF Diabetes Center. He is the recipient of several honors and awards, including the JDRF Scholar Award. He received his Diploma degree in cellular biology from Albert-Ludwigs University in Freiburg, Germany, and performed his PhD thesis at the Max-Planck-Institute for Immunobiology. His postdoctoral research was performed at HHMI at Ha